Compare Cardinal Health Inc (CAH) vs Electronic Arts Inc. (EA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Electronic Arts Inc. — how do they compare? Cardinal Health Inc trades at $229 (market cap $54.72B), while Electronic Arts Inc. trades at $206.65 (market cap $51.74B). The key difference: Cardinal Health Inc and Electronic Arts Inc. are close in size by market cap, and Cardinal Health Inc pays the higher dividend (0.88%). Which is the better fit depends on your goals.
| CAH | EA | |
|---|---|---|
Market Cap | $54.72B | $51.74B |
Sector | Health | Technology |
52-Week High | $239.71 | $206.65 |
52-Week Low | $146.04 | $147.79 |
Enterprise Value | $59.70B | $50.31B |
Dividend Yield | 0.88% | 0.37% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
Electronic Arts (EA) trades at $206.35, down 0.03% on the day, with a bullish technical signal from moving averages and mixed earnings performance including a recent Q4 2025 beat. The company maintains strong profitability with a 78.97% gross margin and 11.78% net margin, though valuation ratios like P/E of 58.79 appear elevated. Recent launches of EA SPORTS College Football 27 and UFC 6, plus the new EA Advertising platform, highlight ongoing growth initiatives.
Outlook is cautiously optimistic given analyst consensus leaning Hold (56.06%) versus Buy (43.94%), with risks including earnings volatility and high valuation. The potential $55 billion acquisition by Saudi investors, pending EU approval, could significantly impact shareholder value, while consistent cash flow from operations supports dividend stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Electronic Arts Inc.
EA is one of the world's largest third-party video game publishers and has transitioned from a console-based video game publisher to the one of the largest publishers on consoles, PC, and mobile. The firm owns number of large franchises, including Madden, FIFA, Battlefield, Apex Legends, Mass Effect, Dragon's Age, and Need for Speed.
Read more on EA →
